Fractyl Health Inc (GUTS) SEC 13F Holdings (Q2 2026) — Net Institutional Activity: -$20.1K

GUTS ranks #5170 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

77 institutions disclose a position in GUTS, but none treat it as a major bet — even M28 Capital Management LP, its most concentrated holder, allocates just 3.1% of its own portfolio to it.

GUTS reported a net loss of $141.0M in its latest fiscal year.

• Not yet profitable — net loss of $141.0M in the latest fiscal year
• Revenue declined 100.0% year over year
• Net income declined year over year, from -$68.7M to -$141.0M
• Operating cash flow was negative, using $90.3M in cash
• Current ratio of 4.78x — enough short-term assets to cover short-term liabilities
• Liabilities run 11.84x equity — a highly leveraged balance sheet worth noting